 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2025 |
|
 |
|
BAYER TO ACQUIRE BIVI'S BOVINE ENDECTOCIDE PRODUCT LINE
Jan. 3, 2017
Ag Business Council of Kansas City reports:
Bayer and Boehringer Ingelheim Vetmedica Inc. (BIVI) announced have signed an agreement under which Bayer will acquire BIVI's CYDECTIN bovine and ovine endectocide products in the U.S.
Once completed, the deal includes the transfer of CYDECTIN Pour-On, CYDECTIN Injectable and CYDECTIN Oral Drench. These endectocides, with the active ingredient moxidectin, offer persistent killing of internal parasites at multiple stages, including the economically devastating Ostertagia ostertagi (brown stomach worm) parasite, and control of external parasites such as lice, grubs and psoroptic mange mites on beef and dairy cattle, according to the announcement.
|
|
|
|
|
